argenx SE (EBR:ARGX)
762.60
-6.20 (-0.81%)
Nov 14, 2025, 9:03 AM CET
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,963,265
Profits / Employee
€817,252
Market Cap
47.05B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,378 |
| Fagron NV | 3,828 |
| Ion Beam Applications | 2,287 |
| Nyxoah | 184 |
| European Medical Solutions | 122 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 49 |
| Sequana Medical NV | 48 |
argenx SE News
- 3 days ago - KROS vs. ARGX: Which Stock Is the Better Value Option? - Nasdaq
- 6 days ago - ARGX: JP Morgan Raises Price Target, Maintains Overweight Rating | ARGX Stock News - GuruFocus
- 7 days ago - Baron International Growth Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 8 days ago - Argenx Gains Health Canada Approval For Vyvgart SC As Monotherapy In CIDP - Nasdaq
- 8 days ago - Argenx (ARGX) Gains Health Canada Approval for CIDP Treatment - GuruFocus
- 10 days ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch
- 13 days ago - ARGX Receives Buy Rating and Raised Price Target by TD Cowen | ARGX Stock News - GuruFocus
- 13 days ago - RBC Capital Raises Price Target for ARGX, Maintains Outperform Rating | ARGX Stock News - GuruFocus